EZH2 and hepatocellular carcinoma: We found that EZH2 expression was significantly positively correlated with various immune cells, including B cells, CD4+ T cells, CD8+ T cells, macrophages, neutrophils, dendritic cells, and CAFs, in HCC tissues.